Role of opioid peptides in disorders of attention in psychopathology.

Buchsbaum MS, Reus VI, Davis GC, Holcomb HH, Cappelletti J, Silberman E

Opiate pharmacology and individual differences. II. Somatosensory evoked potentials.

Buchsbaum MS, Davis GC, Coppola R, Naber D

Opiate pharmacology and individual differences. I. Psychophysical pain measurements.

Buchsbaum MS, Davis GC, Coppola R, Naber D

Strategies for determination of serum or plasma norepinephrine by reverse-phase liquid chromatography.

Davis GC, Kissinger PT, Shoup RE

Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients.

Pickar D, Davis GC, Schulz SC, Extein I, Wagner R, Naber D, Gold PW, van Kammen DP, Goodwin FK, Wyatt RJ, Li CH, Bunney WE Jr

Opiates, opioid peptides and psychiatry.

Davis GC, Buchsbaum MS, Bunney WE Jr

Pain sensitivity and endorphins in functional psychoses.

Davis GC, Buchsbaum MS

Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers.

Naber D, Pickar D, Davis GC, Cohen RM, Jimerson DC, Elchisak MA, Defraites EG, Kalin NH, Risch SC, Buchsbaum MS

Failure of naloxone to reduce manic symptoms.

Davis GC, Extein I, Reus VI, Hamilton W, Post RM, Goodwin FK, Bunney WE Jr

Prolactin response to beta-endorphin in man.

Schulz SC, Wagner B, van Kammen DP, Rogol AD, Davis GC, Wyatt RJ, Pickar D, Bunney WE Jr, Li CH